Eiko Lifesciences (BOM:540204) Construction In Progress: ₹0.0 Mil (As of Mar. 2026)


BOM:540204 Eiko Lifesciences Ltd BOM:540204
74 GF Score
Price ₹50.04
GF Value ₹78.79
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Eiko Lifesciences Construction In Progress?

Eiko Lifesciences BOM:540204 +0.79% 74 Construction In Progress is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:540204 with a GF Score™ of 74/100 and a GF Value™ of ₹78.79 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Eiko Lifesciences Construction In Progress Historical Data

* Premium members only.

The historical data trend for Eiko Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiko Lifesciences Construction In Progress Chart

Eiko Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eiko Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540204
74GF Score
Eiko Lifesciences Ltd BOM:540204
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiko Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0.0 Mil mean?
Eiko Lifesciences (BOM:540204) has a Construction In Progress of ₹0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Eiko Lifesciences and its competitors.
Is Eiko Lifesciences' Construction In Progress too high?
Eiko Lifesciences' current Construction In Progress is ₹0.0 Mil. Overall, Eiko Lifesciences has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' Construction In Progress compare to LIN and SHW?
Eiko Lifesciences' Construction In Progress of ₹0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Chemicals company?
A good Construction In Progress depends on the Chemicals industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Eiko Lifesciences and its competitors. Eiko Lifesciences's current Construction In Progress is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Eiko Lifesciences (BOM:540204) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹78.79, compared to a current price of ₹50.04 — trading 36.5% below its estimated fair value. The current Construction In Progress is ₹0.0 Mil. Eiko Lifesciences' overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Eiko Lifesciences (BOM:540204), the current Construction In Progress is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eiko Lifesciences (BOM:540204) Overvalued in 2026?

Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued. The current stock price of ₹50.04 is trading 36.5% below its estimated GF Value™ of ₹78.79. GuruFocus considers Eiko Lifesciences to be Significantly Undervalued.

Key valuation signals for BOM:540204:

  • Construction In Progress: ₹0.0 Mil
  • GF Value™: ₹78.79 vs. price of ₹50.04 (36.5% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the BOM:540204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eiko Lifesciences Business Description

Address 604, Centrum, Wagle Estate, Opposite TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane, MH, IND, 400604
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
74GF Score

Get the complete analysis for BOM:540204

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹50.04
Price
₹78.79
GF Value